Skip to main content
John Adams, DO, Oncology, Arlington, TX, Texas Health Arlington Memorial Hospital

JohnAdamsDOFACOI

Oncology Arlington, TX

Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology

Physican/ Partner Texas Oncology

Dr. Adams is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Adams' full profile

Already have an account?

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1978 - 1980
  • HCA Healthcare/USF Morsani College of Medicine GME: Largo Medical Center
    HCA Healthcare/USF Morsani College of Medicine GME: Largo Medical CenterResidency, Internal Medicine, 1975 - 1978
  • A. T. Still University Kirksville College of Osteopathic Medicine
    A. T. Still University Kirksville College of Osteopathic MedicineClass of 1975
  • University of Texas at Austin Dell Medical School
    University of Texas at Austin Dell Medical SchoolB.S., Pharmacy, 1964 - 1969

Certifications & Licensure

  • TX State Medical License
    TX State License 1978 - 2025
  • AOA Board of Internal Medicine Internal Medicine
  • AOA Board of Internal Medicine Oncology

Awards, Honors, & Recognition

  • Outstanding Educator Sun Coast Hospital, 1981
  • Scholarship Texas Osteopathic Medical Association, 1971
  • Psi Sigma Alpha - National Osteopathic Scholastic Society
  • Join now to see all

Publications & Presentations

Journal Articles

  • Effects of short-term in vivo administration of G-CSF on bone marrow prior to harvesting  
    Dicke KA, Hood DL, Arneson M, Fulbright L, DiStefano A, Firstenberg B, Adams J, Blumenschein GR, Exp Hematol, 1/1/1997
  • CAVe/XRT/McCFUD as an alternative to high dose chemotherapy and autologous bone marrow support for patients with advanced primary breast cancer  
    Blumenschein G, Jampolis S, DiStefano A, Firstenberg B, Adams J, Caderao J, Speer J, Hanks S, Proc Am Soc Clin Oncol, 1/1/1993
  • Concomitant continuous infusion radiosensitizing chemotherapy and radiation therapy in the treatment of stage 3 non small cell lung cancer  
    Speer J, Adams J, Blumenschein G, Caderao J, DiStefano A, Firstenberg B, Jampolis S, Hanks S, Proc Am Soc Clin Oncol, 1/1/1993

Books/Book Chapters

Abstracts/Posters

  • An aggressive approach to metastatic breast cancer is warranted
    Dicke KA, Blumenschein GR, DiStefano A, Firstenberg B, Adams JW, Arneson MA, Hanks S, Vaughan M, Schweichler LH, Ninth International Symposium on Autologous Blood and Marrow Transplantation; 17th International Cancer Congress (UICC); Current Issues in Cancer Management, Dallas, TX, 1998; Rio de Janeiro, Brazil, 1998, 1/1/1998
  • An aggressive approach to metastatic breast cancer is warranted
    Dicke KA, Blumenschein GR, DiStefano A, Firstenberg B, Adams JW, Arneson MA, Hanks S, Vaughan M, Schweichler LH, 32nd ASCO Annual Meeting; Proceedings of ASCO, Philadelphia, PA, 1/1/1996

Lectures

  • CAVe/XRT/McCFUD as an alternative to high dose chemotherapy (HDC) and autologous bone marrow support (ABMS) for patients with advanced primary breast cancer 
    San Antonio, TX - 1/1/1992
  • Combined modality treatment of advanced primary breast cancer 
    San Antonio, TX - 1/1/1991
  • Vibrio vulnificus infections: Who, Why, Where, and what to do 
    1/1/1989
  • Join now to see all

Professional Memberships

Hospital Affiliations